Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Kava (KAVA) vs Mitosis (MITO) Price & Performance

KavaTrade
MitosisTrade

Price performance (Past 24H)

Key statistics

Kava vs Mitosis — how do they compare? Kava trades at Rp816.68 (market cap Rp896,38M, Rp169,51M 24h volume), while Mitosis trades at Rp388.36 (market cap Rp71,2M, Rp66,32M 24h volume). The key difference: Kava is far larger — about 12.6× Mitosis's market cap, and Mitosis's supply is capped (181,3M / 1B MITO (19%)) while Kava's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Kava for 55 Days and Mitosis for 19 Days on average.

KAVAMITO
Market Cap
Rp896,38MRp71,2M
Volume (24h)
Rp169,51MRp66,32M
Circulating Supply
1,1B KAVA181,3M / 1B MITO (19%)
Typical Hold Time
55 Days19 Days

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Kava

Kava is trading at Rp816.03 with a market cap of Rp882.77 million, showing neutral technical signals overall. The asset is in a consolidation phase near the pivot point of Rp808, with immediate resistance at Rp824 and support at Rp800. Key indicators like RSI_12 at 69.14 suggest neutral momentum, while ADX_6 at 53.20 indicates a strong trend. No major protocol upgrades or ecosystem news have been reported recently, keeping fundamental developments quiet.

The outlook for Kava remains neutral with opportunities in its established support levels but risks from low liquidity and high volatility. Investors should monitor for breakout above Rp824 or breakdown below Rp800, alongside any upcoming network updates that could drive adoption. Major risks include regulatory uncertainty and thin trading volumes exacerbating price swings.

Mitosis

MITO is trading at Rp385.97 with a bearish technical signal, as moving averages indicate strong selling pressure while oscillators remain neutral. The token has a market cap of Rp70.05 million and a low circulation rate of 19%, with key support at Rp352 and resistance at Rp395. Recent news highlights a corporate acquisition of a similarly named entity, but no direct protocol updates were found for the cryptocurrency.

Overall outlook is cautious due to bearish technicals and limited fundamental developments. Key opportunities include potential recovery if support holds, but risks involve low liquidity and minimal ecosystem activity. Investors should monitor for any token-specific news or network updates to reassess positioning.

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

KAVA
44% Buy56% Sell
Avg holding period · 55 Days
MITO
2% Buy98% Sell
Avg holding period · 19 Days

About Kava

KAVA is a cross-chain DeFi lending platform that allows users to borrow USDX stablecoins and deposit a variety of cryptocurrencies to begin earning a yield. Built on the Cosmos blockchain, Kava makes use of a collateralized debt position (CDP) system to ensure stablecoin loans are always sufficiently collateralized.

Read more on KAVA

About Mitosis

Mitosis is a cross-chain DeFi protocol that converts liquidity positions into programmable and composable assets. It tackles two significant inefficiencies in decentralized finance: the illiquidity of staked assets and limited access to high-yield opportunities for smaller users.

Read more on MITO